A detailed history of Sol Capital Management CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Sol Capital Management CO holds 756 shares of LLY stock, worth $601,526. This represents 0.07% of its overall portfolio holdings.

Number of Shares
756
Previous 755 0.13%
Holding current value
$601,526
Previous $684,000 2.05%
% of portfolio
0.07%
Previous 0.08%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$772.14 - $960.02 $772 - $960
1 Added 0.13%
756 $670,000
Q2 2024

Jul 23, 2024

BUY
$724.87 - $909.04 $242,831 - $304,528
335 Added 79.76%
755 $684,000
Q1 2024

Apr 24, 2024

SELL
$592.2 - $792.28 $17,766 - $23,768
-30 Reduced 6.67%
420 $327,000
Q2 2023

Jul 26, 2023

BUY
$350.74 - $468.98 $157,833 - $211,041
450 New
450 $211,000
Q2 2019

Jul 17, 2019

SELL
$110.79 - $129.32 $188,786 - $220,361
-1,704 Closed
0 $0
Q1 2019

Apr 30, 2019

BUY
$111.31 - $131.02 $189,672 - $223,258
1,704 New
1,704 $221,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sol Capital Management CO Portfolio

Follow Sol Capital Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sol Capital Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Sol Capital Management CO with notifications on news.